Skip to main content

In case you missed them, here are the top 10 most widely read articles on

for the past three days (as of June 1). Althea Chang reports on the upcoming ASCO meeting and Dan Fitzpatrick takes a look at U.S. Steel.


Sirius CEO Is Buying by Scott Moritz, published May 30 at 4:55 p.m. EDT.

Karmazin grabs a million shares for the second time this year.


Summer Roller Coaster Just Getting Started by Liz Rappaport, published May 30 at 11:02 a.m. EDT.

Expect more volatile market action until at least the Fed's meeting in late June.


A Fool's Gold Play by Roger Nusbaum, published May 30 at 8:43 a.m. EDT.

The South Africa ETF is frequently cited as an alternative to gold, but it's not a good proxy for the metal.


Ciena's Bright Spot by Scott Moritz, published May 31 at 12:59 p.m. EDT.

The optical networker pursues big customers.


Scroll to Continue

TheStreet Recommends

The Sweet Clatter of Falling Metal by Dan Fitzpatrick, published May 31 at 3:32 p.m. EDT.

Sector rotation out of steel and basic materials stocks offers some low-risk shorts.


Turn Short-Term Fear Into Long-Term Profit by Jim Jubak, published May 31 at 7:23 a.m. EDT.

Market volatility is back, but don't let it scare you. Short-term bumps can become opportunities.


Vonage Keeps Sinking by Jonathan Berr, published May 31 at 10:08 p.m. EDT.

The stock drops again as observers ponder the next move.


The Market May Have Bottomed by Alan Farley, published May 30 at 3:54 p.m. EDT.

We could be about to embark on a rocky climb back to the year's highs.


Big Win for Tech Stocks by Robert Holmes, published June 1 at 4:36 p.m. EDT.

The Nasdaq jumps 1.9%. The S&P 500 has now erased all of this week's earlier losses.


Biotech Firms Are Bracing for ASCO by Althea Chang, published June 1 at 7:18 a.m. EDT.

The annual cancer conference is here again. This time, Avastin has to share the stage.

David Morrow is editor-in-chief of In keeping with TSC's editorial policy, he doesn't own or short individual stocks, though he owns stock in He also doesn't invest in hedge funds or other private investment partnerships. He appreciates your feedback;

click here

to send him an email.